Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson Jan 16, 2015 9:18am

66 Views

Post# 23327066

RE:the problem is that you have to be spot on

65corvettesting wrote: with your protocol before you enter FDA because there is no turning back and its very costly. the time spent now is so valuable in so way ways. common sense. time lines will change. a basher is a person that always looks at the glass half empty. plus they likely get .10 cents/post=about 10 dollars a day or a hot dog and a pop. lol

This is probably one of yesterdays best insights. We've said it before but the legwork being done now by the best specialists in the field and doing it right the first time justifies delays. Enrollment will start by Q3 imo

Bullboard Posts

Shopify stock hits year-high on Q3 results